Aligos Therapeutics, Inc.
USD5.74
-0.01 (-0.17%)
CEO
Lawrence Blatt
IPO Date
2020-10-16
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$5.70
Prev. Close
$5.75
Day Low
$5.60
Day High
$5.85
52W Low
$4.80
52W High
$13.69
Market Cap
$0.04B
Volume
0.05M
| 5,860 |
| $5.50 |
| 29 Jun 2026 | Martell Bridget A | director | A-Award | Acquired | 5,860 | $5.50 |
| 29 Jun 2026 | Scopa James Paul | director | A-Award | Acquired | 5,860 | $5.50 |
| 29 Jun 2026 | Nuechterlein Carole | director | A-Award | Acquired | 5,860 | $5.50 |
| 29 Jun 2026 | Hirth Peter | director | A-Award | Acquired | 5,860 | $5.50 |
| 11 Mar 2026 | Aneja Nikhil | Principal Accounting Officer | A-Award | Acquired | 9,450 | $7.03 |
| 11 Mar 2026 | Calhoun Lesley Ann | See Remarks | A-Award | Acquired | 37,485 | $7.03 |
| 11 Mar 2026 | BLATT LAWRENCE | director, officer: President and CEO | A-Award | Acquired | 105,840 | $7.03 |
| 19 Feb 2026 | Aneja Nikhil | Principal Accounting Officer | Disposed | 3,800 | $16.00 |